Johns Hopkins logo

Health Newsfeed

WHY PSILOCYBIN?

ANCHOR LEAD: WHAT CAN BE DONE TO ALLEVIATE DEPRESSION AND ANXIETY RELATED TO A CANCER DIAGNOSIS?  ELIZABETH TRACEY REPORTS

An ongoing study at Johns Hopkins and two other academic medical centers is using psilocybin to alleviate anxiety and depression in people with cancer, with early results reported recently looking very promising.  But can such a study be undertaken if cancer treatment is still underway?  Roland Griffiths, study investigator at Johns Hopkins, says yes.

GRIFFITHS:  The study is open to people who both have progressing illness or if they have significant anxiety or depression and even if they believe their cancer’s been resolved if that psychological distress remains they too would be eligible.  It is the case that anxiety and depression are extraordinarily common among cancer patients.   :24

Griffiths says that people who have just received a cancer diagnosis as well as those whose disease has progressed are eligible to participate.   Prospective participants can expect to be screened for significant anxiety and depression relative to their cancer diagnosis.  At Johns Hopkins, I’m Elizabeth Tracey.


Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home